
Pandemic and All-Hazards Preparedness Act (PAHPA) Policy Brief

The Impact of Investing in Health Equity in Biomedical Research

Virtual Program | A Conversation with Marcella Nunez-Smith on COVID-19 and Health Equity

Comments on FDA’s Draft Guidance for Industry, Investigators, and Other Stakeholders on Decentralized Clinical Trials for Drugs, Biological Products, and Devices - Docket ID FDA-2022-D-2870
